A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database

Patel, NM; Stottlemyer, BA; Gray, MP; Boyce, RD; Kane-Gill, SL

Kane-Gill, SL (corresponding author), Univ Pittsburgh, Sch Pharm, 3507 Terrace St, Pittsburgh, PA 15261 USA.

CARDIOVASCULAR DRUGS AND THERAPY, ; ():

Abstract

Purpose Between 2012 and 2017, the FDA approved 29 therapies for a cardiovascular disease (CVD) indication. Due to the limited literature on patient s......

Full Text Link